Summary
The product CIALIS 10, submitted by Axle Labs, underwent independent testing to verify its authenticity and potency. The manufacturer details were not provided, and the sample was identified by batch number 010 Exp. 10/27. The sample was analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control, and tested for the presence of Tadalafil.
The testing process began on 26 August 2024, with the sample received on 30 August 2024, and analysis completed on 31 August 2024. The analysis confirmed the presence of Tadalafil at concentrations of 11.82 mg, 9.67 mg, and 8.90 mg, which varies slightly from the expected 10 mg per unit. These variations suggest potential inconsistencies in the formulation. Independent third-party testing remains essential to ensure consistency and product reliability across different batches. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Axle Labs
- Product Name: CIALIS 10
- Active Ingredient: Tadalafil
- Batch Number: 010 Exp. 10/27
- Expiration Date: October 2027
- Delivery Method: Oral
Sample Acquisition and Testing
- Task Number: #48264
- Testing Ordered: 26 August 2024
- Sample Received: 30 August 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Axle Labs (Manufacturer)
- Analysis Paid For By: Axle Labs (Manufacturer)
Testing Results
- Specification: 10 mg (as expected)
- Measured Concentrations: 11.82 mg, 9.67 mg, 8.90 mg
- Purity Assessment: No additional data provided
Verification Details
Verification URL: https://janoshik.com/tests/48264_NH4SKMKJULW2
Evaluation of Submitted Testing
This analysis confirms the presence of Tadalafil in CIALIS 10, with measured concentrations ranging from 8.90 mg to 11.82 mg, which varies slightly from the expected dosage. While the deviations are moderate, they indicate potential inconsistencies in formulation. The lack of manufacturer details and batch oversight necessitates further scrutiny to ensure formulation accuracy across multiple samples. Janoshik Analytical is recognized for its transparency and rigorous testing protocols; however, further third-party validation is recommended.
Conclusion
The analysis confirms that CIALIS 10 contains Tadalafil at an average concentration close to 10 mg, though with some variation in the tested units. This highlights the importance of batch-to-batch consistency in pharmaceutical formulations. This report is provided to support educational and harm reduction efforts, helping consumers make informed choices regarding pharmaceutical products.
Disclaimer
This report is published for educational and harm reduction purposes. Submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
